table of content
1 Introduction to Research & Analysis Reports
1.1 Retinal Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Retinal Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Biologics Overall Market Size
2.1 Global Retinal Biologics Market Size: 2022 VS 2032
2.2 Global Retinal Biologics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Retinal Biologics Players in Global Market
3.2 Top Global Retinal Biologics Companies Ranked by Revenue
3.3 Global Retinal Biologics Revenue by Companies
3.4 Top 3 and Top 5 Retinal Biologics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Retinal Biologics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Biologics Players in Global Market
3.6.1 List of Global Tier 1 Retinal Biologics Companies
3.6.2 List of Global Tier 2 and Tier 3 Retinal Biologics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Retinal Biologics Market Size Markets, 2022 & 2032
4.1.2 Macular Degeneration
4.1.3 Diabetic Retinopathy
4.1.4 Diabetic Macular Edema
4.1.5 Uveitis
4.1.6 Others
4.2 By Type - Global Retinal Biologics Revenue & Forecasts
4.2.1 By Type - Global Retinal Biologics Revenue, 2018-2023
4.2.2 By Type - Global Retinal Biologics Revenue, 2024-2032
4.2.3 By Type - Global Retinal Biologics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Biologics Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Retinal Biologics Revenue & Forecasts
5.2.1 By Application - Global Retinal Biologics Revenue, 2018-2023
5.2.2 By Application - Global Retinal Biologics Revenue, 2024-2032
5.2.3 By Application - Global Retinal Biologics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Retinal Biologics Market Size, 2022 & 2032
6.2 By Region - Global Retinal Biologics Revenue & Forecasts
6.2.1 By Region - Global Retinal Biologics Revenue, 2018-2023
6.2.2 By Region - Global Retinal Biologics Revenue, 2024-2032
6.2.3 By Region - Global Retinal Biologics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Retinal Biologics Revenue, 2018-2032
6.3.2 US Retinal Biologics Market Size, 2018-2032
6.3.3 Canada Retinal Biologics Market Size, 2018-2032
6.3.4 Mexico Retinal Biologics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Retinal Biologics Revenue, 2018-2032
6.4.2 Germany Retinal Biologics Market Size, 2018-2032
6.4.3 France Retinal Biologics Market Size, 2018-2032
6.4.4 U.K. Retinal Biologics Market Size, 2018-2032
6.4.5 Italy Retinal Biologics Market Size, 2018-2032
6.4.6 Russia Retinal Biologics Market Size, 2018-2032
6.4.7 Nordic Countries Retinal Biologics Market Size, 2018-2032
6.4.8 Benelux Retinal Biologics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Retinal Biologics Revenue, 2018-2032
6.5.2 China Retinal Biologics Market Size, 2018-2032
6.5.3 Japan Retinal Biologics Market Size, 2018-2032
6.5.4 South Korea Retinal Biologics Market Size, 2018-2032
6.5.5 Southeast Asia Retinal Biologics Market Size, 2018-2032
6.5.6 India Retinal Biologics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Retinal Biologics Revenue, 2018-2032
6.6.2 Brazil Retinal Biologics Market Size, 2018-2032
6.6.3 Argentina Retinal Biologics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Retinal Biologics Revenue, 2018-2032
6.7.2 Turkey Retinal Biologics Market Size, 2018-2032
6.7.3 Israel Retinal Biologics Market Size, 2018-2032
6.7.4 Saudi Arabia Retinal Biologics Market Size, 2018-2032
6.7.5 UAE Retinal Biologics Market Size, 2018-2032
7 Retinal Biologics Companies Profiles
7.1 Spark Therapeutics, Inc
7.1.1 Spark Therapeutics, Inc Company Summary
7.1.2 Spark Therapeutics, Inc Business Overview
7.1.3 Spark Therapeutics, Inc Retinal Biologics Major Product Offerings
7.1.4 Spark Therapeutics, Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.1.5 Spark Therapeutics, Inc Key News & Latest Developments
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Company Summary
7.2.2 F. Hoffmann-La Roche Ltd Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.3 Regeneron Pharmaceuticals, Inc
7.3.1 Regeneron Pharmaceuticals, Inc Company Summary
7.3.2 Regeneron Pharmaceuticals, Inc Business Overview
7.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Major Product Offerings
7.3.4 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.3.5 Regeneron Pharmaceuticals, Inc Key News & Latest Developments
7.4 AbbVie Inc
7.4.1 AbbVie Inc Company Summary
7.4.2 AbbVie Inc Business Overview
7.4.3 AbbVie Inc Retinal Biologics Major Product Offerings
7.4.4 AbbVie Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.4.5 AbbVie Inc Key News & Latest Developments
7.5 Johnson & Johnson Services, Inc
7.5.1 Johnson & Johnson Services, Inc Company Summary
7.5.2 Johnson & Johnson Services, Inc Business Overview
7.5.3 Johnson & Johnson Services, Inc Retinal Biologics Major Product Offerings
7.5.4 Johnson & Johnson Services, Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Services, Inc Key News & Latest Developments
7.6 Amgen Inc
7.6.1 Amgen Inc Company Summary
7.6.2 Amgen Inc Business Overview
7.6.3 Amgen Inc Retinal Biologics Major Product Offerings
7.6.4 Amgen Inc Retinal Biologics Revenue in Global Market (2018-2023)
7.6.5 Amgen Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
